PubMed=1828972; DOI=10.1016/0277-5379(91)90241-5
Nouri A.M.E., Bergbaum A., Lederer E., Crosby D., Shamsa A., Oliver R.T.D.
Paired tumour infiltrating lymphocyte (TIL) and tumour cell line from bladder cancer: a new approach to study tumour immunology in vitro.
Eur. J. Cancer 27:608-612(1991)

PubMed=8512807; DOI=10.1038/bjc.1993.229; PMCID=PMC1968525
Nouri A.M.E., Hussain R.F., Dos Santos A.V.L., Mansouri M., Oliver R.T.D.
Intensity of class I antigen expression on human tumour cell lines and its relevance to the efficiency of non-MHC-restricted killing.
Br. J. Cancer 67:1223-1228(1993)

PubMed=10948322; DOI=10.3892/or.7.5.959
Nouri A.M.E., Symes M.O.
Comparative assessment of MHC antigen expression in bladder and testis tumour biopsies and established urological tumour cell lines: the relevance of cytokine and gene transfection for correction of defective MHC antigens.
Oncol. Rep. 7:959-964(2000)

PubMed=12127398; DOI=10.1016/S0165-4608(01)00648-3
Strefford J.C., Lillington D.M., Steggall M., Lane T.M., Nouri A.M.E., Young B.D., Oliver R.T.D.
Novel chromosome findings in bladder cancer cell lines detected with multiplex fluorescence in situ hybridization.
Cancer Genet. Cytogenet. 135:139-146(2002)

PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350
Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.
Systematic review: characteristics and preclinical uses of bladder cancer cell lines.
Bladder Cancer 4:169-183(2018)